ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1014

Distinct Macrophage Phenotype and Bioenergetic Profiles in Rheumatoid Arthritis

Megan M. Hanlon1, Mary Canavan1, Trudy McGarry1, Candice Low2, Siobhan C. Wade1, Douglas J. Veale2 and Ursula Fearon1, 1Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 2Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Macrophage, Synovial Immune Biology and metabolism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Innate Immunity Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial macrophages play a key role in RA disease progression, yet the diversity of macrophage subsets within the joint remains unknown. The concept of macrophage polarization into M1 inflammatory macrophages and M2 tissue-resolving macrophages, parallelled by changes in the bioenergetic cell profile, has received much attention. However the diversity and plasticity of macrophage subsets and their metabolic profile within the joint has yet to be elucidated.

Methods: Synovial tissue biopsies from Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Osteoarthritis (OA) were obtained through key-hole arthroscopy. To phenotype distinct macrophage subtypes in the RA joint, synovial tissue biopsies (~10-15) were enzymatically and physically digested using an enzymatic cocktail and the GentleMACs dissociation system to yield a synovial single cell suspension. RA, PsA and OA synovial cell suspensions along with synovial fluid mononuclear cells were stained using a specific antibody panel (CD40, CD45, CD64, CD68, CD163, CD206, CD253) and analysed by advanced-multicolour flow cytometry analysis. Blood was also obtained from healthy and RA donors, CD14+ cells sorted and differentiated into macrophages for 8 days and polarised to either M1 (LPS/IFNγ) or M2 (IL-4) macrophages. Inflammatory and metabolic genes were measured by RT-PCR. The two major energy-using pathways, glycolysis (ECAR) and oxidative phosphorylation (OCR) were measured by Seahorse XFE technology.

Results: M1 cells displayed higher expression of pro-inflammatory genes and demonstrated a pro-glycolytic phenotype with significant increases in HIF1α, HK2, LDHA and PFKFB3, compared to M2, this effect was then further exacerbated in RA macrophages compared to healthy control. Using seahorse technology we demonstrate that in RA, both M1 and M2 macrophages display higher ECAR and OCR profiles compared to HC indicating that RA macrophages are more metabolically active compared to HC. Furthermore we note increased ECAR:OCR profiles in RA vs HC, thus RA macrophages utilise glycolysis more readily than HC. Flow cytometry analysis of RA synovial tissue and fluid revealed that CD68+ macrophages display markers typical of both M1 (CD40+CD253+) and M2 (CD206+CD163+). A significant increase in the frequency of CD68+ and CD64+ macrophages in the synovial tissue compared to fluid was observed, along with significant increases in marker expression of CD40, CD163 and CD206. Further analysis revealed a spectrum of macrophage subtypes exists within the inflamed joint, with a dominant macrophage subtype consisting of double positive CD206+ CD163+ identified, which is enriched in the synovial tissue compared to synovial fluid. Furthermore, we demonstrate that the frequency of this enriched population is significantly increased in RA synovial tissue compared to that of PsA and OA synovial tissue.

Conclusion: This study demonstrates distinct metabolic profiles in M1/M2 RA macrophages; associated with differences in key inflammatory mediators. Furthermore, we have identified, for the first time, a dominant subtype of RA tissue-specific macrophages, suggesting that these cells remain plastic and their function dependent on their microenvironment.


Disclosure: M. M. Hanlon, None; M. Canavan, None; T. McGarry, None; C. Low, None; S. C. Wade, None; D. J. Veale, None; U. Fearon, None.

To cite this abstract in AMA style:

Hanlon MM, Canavan M, McGarry T, Low C, Wade SC, Veale DJ, Fearon U. Distinct Macrophage Phenotype and Bioenergetic Profiles in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/distinct-macrophage-phenotype-and-bioenergetic-profiles-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-macrophage-phenotype-and-bioenergetic-profiles-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology